Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.660
-0.160 (-8.79%)
At close: Feb 5, 2026, 4:00 PM EST
1.660
0.00 (0.00%)
After-hours: Feb 5, 2026, 4:58 PM EST
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $27.68 million as of February 5, 2026. Its market cap has increased by 51.24% in one year.
Market Cap
27.68M
Enterprise Value
12.76M
1-Year Change
51.24%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $27.68M, a decrease of -39.57%. That is a compound annual growth rate of -5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 30.30M | 22.18% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 32.20M |
| Liminatus Pharma | 31.67M |
| Werewolf Therapeutics | 30.68M |
| Dyadic International | 30.44M |
| NeuroSense Therapeutics | 30.38M |
| AN2 Therapeutics | 30.14M |
| Palatin Technologies | 29.61M |
| Cue Biopharma | 29.49M |